Jason A. Mouabbi: In this era of ADC’s, precision is the name of the game
Jason A. Mouabbi, Assistant professor of breast medical oncology at The University of Texas MD Anderson Cancer Center, shared on X:
“In this era of ADC’s, precision is the name of the game! Don’t miss poster P01-03-19 at SABCS24, where we unveil a comprehensive analysis of ADC target expression in lobular ILC cancer. Let’s shape the future of tailored therapies together!”
Jason A. Mouabbi is assistant professor of breast medical oncology at The University of Texas MD Anderson Cancer Center, Houston, Texas. He joined the LBCA SAB in early 2021. He has won awards like GRASP Award in 2022, Top Doctor Award, Detroit Hour Magazine in 2019 and more. His research is focused on highlighting the differences between invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) for the past eight years.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023